RETINITIS PIGMENTOSA (RP)
Clinical trials for RETINITIS PIGMENTOSA (RP) explained in plain language.
Never miss a new study
Get alerted when new RETINITIS PIGMENTOSA (RP) trials appear
Sign up with your email to follow new studies for RETINITIS PIGMENTOSA (RP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to save sight in rare genetic disorder
Disease control Not yet recruitingThis study tests whether an experimental drug called NPI-001 can slow the loss of light-sensing cells in the eyes of people with Usher syndrome, a genetic condition that causes both hearing and vision loss. About 80 adults will take either the drug or a placebo twice daily for tw…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase: PHASE3 • Sponsor: Nacuity Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 10:50 UTC
-
Gene therapy shot aims to slow vision loss in rare eye disease
Disease control Not yet recruitingThis early-stage study tests a single injection of a gene therapy called UGX202 in 6 adults with advanced retinitis pigmentosa, a genetic eye disease that causes vision loss. The main goal is to check if the treatment is safe and tolerable over 52 weeks. Researchers will also loo…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase: EARLY_PHASE1 • Sponsor: Suzhou UgeneX Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New injection aims to slow vision loss in rare eye disease
Disease control Not yet recruitingThis early-stage trial tests a new injection called ZM-02 for people with advanced retinitis pigmentosa, a genetic condition that causes progressive vision loss. The study will include 21 participants aged 6 to 60 and will compare the injection to a sham procedure to check safety…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase: PHASE1, PHASE2 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Brain zaps may boost mobility in visually impaired
Symptom relief Not yet recruitingThis small pilot study tests whether a safe, non-invasive brain stimulation can temporarily improve orientation and mobility in adults with tunnel vision from conditions like retinitis pigmentosa or glaucoma. Twenty participants will complete an obstacle course after receiving ei…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Phase: NA • Sponsor: University of Waterloo • Aim: Symptom relief
Last updated May 13, 2026 16:04 UTC
-
Eye disease study aims to map vision loss to help future treatments
Knowledge-focused Not yet recruitingThis study looks at 200 people with inherited retinal diseases like retinitis pigmentosa and Stargardt disease. Researchers will review past eye exams and genetic tests to see how vision changes over time and how different genes affect the disease. The goal is to better understan…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 17, 2026 10:49 UTC
-
New eye scanner could reveal hidden clues in common eye diseases
Knowledge-focused Not yet recruitingThis study will test a new, non-invasive eye scanner (wide field OCTA) in 200 adults with various eye diseases like age-related macular degeneration, diabetic retinopathy, and uveitis. The goal is to see if this device provides better images of blood vessels in the back and front…
Matched conditions: RETINITIS PIGMENTOSA (RP)
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC